In this study, we evaluated the genetic heterogeneity of the studies included and then carried out a meta-analysis on the association between the MAPT SNPs (rs242557, rs2471738, rs3785883 and rs1467967) with AD risk to make a more accurate assessment of the relationship for greater power in detecting the disease associations. This evidence concerns the gene MAPT and Alzheimer disease.